Literature DB >> 10861289

Mammalian artificial chromosome formation from circular alphoid input DNA does not require telomere repeats.

T A Ebersole1, A Ross, E Clark, N McGill, D Schindelhauer, H Cooke, B Grimes.   

Abstract

Mammalian artificial chromosomes (MACs) form in HT1080 cells after transfecting linear yeast artificial chromosome constructs minimally containing competent alphoid arrays, a selectable marker and terminal human telomere repeats. Restrictions on the structure of input DNA in MAC formation were investigated by transfecting circular or linear alphoid constructs with or without human telomere arrays and by varying the position and orientation of the telomere arrays on input linear constructs. Circular input DNA efficiently produced MACs. Absence of telomere arrays from circular input molecules did not significantly alter MAC formation rates. Linear constructs capped with telomere arrays generated MACs effectively, but a severe reduction in MAC formation was observed from linear constructs lacking telomere arrays. Human telomere arrays positioned 1-5 kb from linear construct ends and in either orientation were able to promote MAC formation with similar efficiencies. Both circular and linear input constructs generated artificial chromosomes that efficiently segregated in the absence of selection. Telomeres were not detected on the MACs, regardless of the inclusion of telomere arrays on input DNA, suggesting that circular chromosomes were formed. We found no evidence for acquisition of host cell DNA, which is consistent with de novo chromosome assembly.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861289     DOI: 10.1093/hmg/9.11.1623

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  53 in total

1.  Neocentromeres and human artificial chromosomes: an unnatural act.

Authors:  H F Willard
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

2.  Co-localization of centromere activity, proteins and topoisomerase II within a subdomain of the major human X alpha-satellite array.

Authors:  Jennifer M Spence; Ricky Critcher; Thomas A Ebersole; Manuel M Valdivia; William C Earnshaw; Tatsuo Fukagawa; Christine J Farr
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

3.  Topoisomerase II cleavage activity within the human D11Z1 and DXZ1 alpha-satellite arrays.

Authors:  Jennifer M Spence; R E Keith Fournier; Mitsuo Oshimura; Vinciane Regnier; Christine J Farr
Journal:  Chromosome Res       Date:  2005-09-21       Impact factor: 5.239

Review 4.  Artificial and engineered chromosomes: developments and prospects for gene therapy.

Authors:  Brenda R Grimes; Zoia Larin Monaco
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

5.  A minimal CENP-A core is required for nucleation and maintenance of a functional human centromere.

Authors:  Yasuhide Okamoto; Megumi Nakano; Jun-ichirou Ohzeki; Vladimir Larionov; Hiroshi Masumoto
Journal:  EMBO J       Date:  2007-02-22       Impact factor: 11.598

Review 6.  Human artificial chromosomes for gene delivery and the development of animal models.

Authors:  Yasuhiro Kazuki; Mitsuo Oshimura
Journal:  Mol Ther       Date:  2011-07-12       Impact factor: 11.454

7.  Engineered plant minichromosomes: a bottom-up success?

Authors:  Andreas Houben; R Kelly Dawe; Jiming Jiang; Ingo Schubert
Journal:  Plant Cell       Date:  2008-01-25       Impact factor: 11.277

8.  Interspecific transfer of mammalian artificial chromosomes between farm animals.

Authors:  Filomena Monica Cavaliere; Gian Luca Scoarughi; Carmen Cimmino
Journal:  Chromosome Res       Date:  2009-07-23       Impact factor: 5.239

Review 9.  The unique kind of human artificial chromosome: Bypassing the requirement for repetitive centromere DNA.

Authors:  Craig W Gambogi; Jennine M Dawicki-McKenna; Glennis A Logsdon; Ben E Black
Journal:  Exp Cell Res       Date:  2020-04-01       Impact factor: 3.905

Review 10.  A new generation of human artificial chromosomes for functional genomics and gene therapy.

Authors:  Natalay Kouprina; William C Earnshaw; Hiroshi Masumoto; Vladimir Larionov
Journal:  Cell Mol Life Sci       Date:  2012-08-21       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.